2012, Patients and Supply Chain - Primary Care Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

Patients

Supply Chain

News on FDA’s Quality Management Maturity Program-Maturity to Continually Improve and to not be Reactive

FDA Law

MARCH 1, 2023

In this report, it’s stated that 62% of drug shortages reported between 2012 and 2017 were due to quality issues which is attributed in part to a lack of recognition or reward for manufacturers with mature quality management systems that focus on continuous improvement and early detection of supply chain issues.

Management

Management Manufacturing Supply Chain Provider

Does the Drug Shortage White Paper Fall Short?

FDA Law

APRIL 8, 2024

Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response.

Supply Chain

Supply Chain Manufacturing Government Hospital

News on FDA’s Quality Management Maturity Program-Maturity to Continually Improve and to not be Reactive

Does the Drug Shortage White Paper Fall Short?

Stay Connected